|
|
Transcripts that showed significantly increased expression in ogt-1(ok1474) neuronal cells isolated by FACs comparing to in FACs isolated neuronal cells from wild type. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00066485:ogt-1(ok1474)_upregulated_neuron
|
|
|
Transcripts that showed significantly increased expression in daf-2(e1370) neurons comparing to in N2 neurons at day 8adult stage. |
DESeq2, FDR < 0.05, fold change > 2. |
WBPaper00066978:daf-2(e1370)_upregulated_neuron
|
|
|
Transcripts that showed significantly increased expression in daf-16(mu86);daf-2(e1370) neurons comparing to in daf-2(e1370) neurons at day 8adult stage. |
DESeq2, FDR < 0.05, fold change > 2. |
WBPaper00066978:daf-16(mu86)_upregulated_neuron
|
|
|
Transcripts that showed significantly increased expression in ints-1(RNAi) animals comparing to control RNAi animals, at late L3 larva stage. |
DESeq2, v1.12.0, fold change > 2, FDR < 0.05 |
WBPaper00057068:ints-4(RNAi)_upregulated
|
|
|
Transcripts that showed significantly increased expression in animals after 24 hour exposure to 100ug per ml silica nanoparticles (SiNPs). |
The random variance model (RVM)t-test was applied toidentify differentially expressed mRNAs and miRNAsbetween the SiNPs-treated group and the control group. P-value <0.05 and fold change (FC) >1.5 were considered as the threshold screening between the SiNP-treated groupand the control group. |
WBPaper00060100:SiNP_upregulated_mRNA
|
|
|
Transcripts that showed significantly decreased expression in adr-1(tm668) comparing to in N2. |
DESeq2, p-value < 0.05 and a fold enrichment log2fold > 0.5. |
WBPaper00055226:adr-1(tm668)_downregulated
|
|
|
ncRNAs with significantly increased expression in cep-1(gk138) than in N2 under normal conditions, according to RNAseq. |
ncRNAs with more than 2 fold difference in expression are considered differentially expressed |
WBPaper00045380:cep-1(gk138)_upregulated_normal
|
